Clinical Trials Insight: 700027311
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2009
At a glance
- Drugs Danoprevir; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Sponsors InterMune
- 24 Apr 2009 Results were presented in an InterMune media release and at the 44th Annual Meeting of the European Association for the Study of the Liver.
- 12 Jan 2009 Top-line results are reported in an InterMune media release.
- 12 Jan 2009 Status changed from recruiting to completed, according to a InterMune media release.